| Drug Safety & PHV Diagnostic Assessment |
| November 14, 2007 |
Speaker: |
Steve Jolley, Associate Vice-President & Head of Pharmacovigilance,
Patni Life Sciences
|
| |
| Webinar Highlights |
Is your Drug Safety program prepared to handle a new product or merger? Do you have an objective picture of your regulatory and business risks? To make sure your response can be "yes" to these questions, Patni Life Sciences has developed Operations Intelligence-PVTM, a diagnostic assessment that will help improve the efficiency and quality of your Pharmacovigilance processes and systems to ultimately facilitate early warning of any safety issues.
In this complimentary webinar, Steve Jolley, AVP and Head of
Pharmacovigilance, Patni Life Sciences, discussed:
 |
The impact of ICH, FDA, MHRA and MHLW regulations on international safety reporting and review methods to meet requirements |
|
The objects and components of a pharmacovigilance assessment |
|
